Following a record-setting spate of settlements, GlaxoSmithKline North America President Dierdre Connelly touts Glaxo’s move away from a sales model that encourages the misbehavior that got the company into trouble, and rejects the argument that fines and settlements are insufficient to change the industry’s behavior. “Our settlement … damaged our reputation and it hurt our morale,” she stated.
And if anyone believes this I have a plot of swampland to sell you!
Report comment